Symbols / IGA Stock $9.65 -0.10% Voya Global Advantage and Premium Opportunity Fund
IGA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Voya Global Advantage and Premium Opportunity Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by Voya Investments, LLC, Voya Investment Management Co. LLC, and NNIP Advisors B.V. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value stocks of companies across all market capitalizations. The fund also invests through index call options on selected indices, equities, and/or exchange-traded funds. It employs fundamental analysis with a bottom-up stock picking approach and a proprietary discounted cash flow valuation model, focusing on such factors as sales, margins, and capital use to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index. It was formerly known as ING Global Advantage and Premium Opportunity Fund. Voya Global Advantage and Premium Opportunity Fund was formed on July 7, 2005 and is domiciled in the United States.
Ratings
Current target
$9.65
Low
—
High
—
Mean
—
News
RSS: Latest IGA news- IGA Struggles to Stock Shelves Due to Difficulties with Wholesalers - The Oberlin Review Fri, 14 Nov 2025 08
- How Voya Global Advantage And Premium Opportunity Fund Of Beneficial Interest (IGA) Affects Rotational Strategy Timing - Stock Traders Daily Fri, 10 Apr 2026 17
- IGA: NAV Erosion Likely To Continue (Rating Downgrade) - Seeking Alpha Wed, 08 Apr 2026 07
- Mirra Andreeva shares her thoughts on Iga Swiatek ahead of their Stuttgart meeting - Yahoo Sports Fri, 17 Apr 2026 07
- The 7 Best IgA Nephropathy Resources of 2026 - Everyday Health hu, 02 Apr 2026 21
- Is Voya (IGA) Stock Overpriced Now | Price at $9.53, Down 0.67% - RSI Overbought Stocks - Cổng thông tin điện tử tỉnh Tây Ninh Mon, 13 Apr 2026 07
- How to accelerate onboarding and achieve full app coverage in your IGA program - SC Media ue, 04 Nov 2025 08
- Vertex jumps after positive Phase 3 interim data for povetacicept in IgA nephropathy - Quiver Quantitative Mon, 09 Mar 2026 07
- MONOPOLY lands in the casino pit as Galaxy Gaming heads to IGA - Stock Titan Mon, 23 Mar 2026 07
- Voya (IGA) Stock: Downside Overview (Technical Weakness) 2026-04-20 - Shared Momentum Picks - UBND thành phố Hải Phòng Mon, 20 Apr 2026 06
- Vertex Advances FDA Filing for IgA Nephropathy Therapy - TipRanks ue, 31 Mar 2026 07
- IGA: Discount Widens Back Out, Making It A More Interesting Choice (Upgrade) (NYSE:IGA) - Seeking Alpha hu, 09 Apr 2026 07
- How Vertex’s IgA Nephropathy Data and Accelerated FDA Pathway At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story - Yahoo Finance Sun, 22 Mar 2026 07
- Is Voya (IGA) Stock Overpriced Now | Price at $9.53, Down 0.67% - Popular Trader Picks - Xã Vĩnh Công Mon, 13 Apr 2026 07
- Low-IgA immune therapy now ready-to-use for U.S. PI patients - Stock Titan hu, 22 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 |
|---|---|---|---|---|---|
| Total Revenue |
|
23.25
+112.47%
|
10.94
+133.65%
|
4.68
-80.90%
|
24.52
|
| Operating Revenue |
|
23.25
+112.47%
|
10.94
+133.65%
|
4.68
-80.90%
|
24.52
|
| Operating Expense |
|
0.23
+1.33%
|
0.23
-1.43%
|
0.23
-45.78%
|
0.43
|
| Selling General And Administration |
|
0.25
+16.77%
|
0.21
-18.01%
|
0.26
-38.60%
|
0.43
|
| General And Administrative Expense |
|
0.25
+16.77%
|
0.21
-18.01%
|
0.26
-38.60%
|
0.43
|
| Other Operating Expenses |
|
-0.02
-201.01%
|
0.02
+159.73%
|
-0.03
-565.99%
|
0.01
|
| Net Income |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Pretax Income |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Net Interest Income |
|
0.02
-20.60%
|
0.02
+36.91%
|
0.01
|
—
|
| Interest Income |
|
0.02
-20.60%
|
0.02
+36.91%
|
0.01
|
—
|
| Gain On Sale Of Security |
|
9.93
+752.60%
|
-1.52
-118.97%
|
8.02
-61.57%
|
20.87
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Net Income From Continuing Operation Net Minority Interest |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Net Income From Continuing And Discontinued Operation |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Net Income Continuous Operations |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Normalized Income |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Net Income Common Stockholders |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Diluted EPS |
|
1.51
+104.05%
|
0.74
+131.25%
|
0.32
-76.81%
|
1.38
|
| Basic EPS |
|
1.51
+104.05%
|
0.74
+131.25%
|
0.32
-76.81%
|
1.38
|
| Basic Average Shares |
|
15.24
+5.30%
|
14.48
+4.12%
|
13.90
-20.35%
|
17.46
|
| Diluted Average Shares |
|
15.24
+5.30%
|
14.48
+4.12%
|
13.90
-20.35%
|
17.46
|
| Diluted NI Availto Com Stockholders |
|
23.02
+114.87%
|
10.71
+140.77%
|
4.45
-81.53%
|
24.09
|
| Line Item | Trend | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 |
|---|---|---|---|---|---|
| Total Assets |
|
162.03
+4.51%
|
155.03
-3.54%
|
160.72
-7.65%
|
174.04
|
| Cash And Cash Equivalents |
|
0.33
+4.49%
|
0.32
-8.21%
|
0.35
-52.97%
|
0.73
|
| Cash Financial |
|
0.33
+4.49%
|
0.32
-8.21%
|
0.35
-52.97%
|
0.73
|
| Receivables |
|
1.07
+212.59%
|
0.34
-67.85%
|
1.07
-7.51%
|
1.15
|
| Taxes Receivable |
|
0.21
+11.19%
|
0.19
-3.45%
|
0.20
-5.18%
|
0.21
|
| Prepaid Assets |
|
0.00
-55.61%
|
0.00
+244.01%
|
0.00
+5466.67%
|
0.00
|
| Investments And Advances |
|
159.41
+4.32%
|
152.81
-3.25%
|
157.94
-7.87%
|
171.43
|
| Total Liabilities Net Minority Interest |
|
1.76
+2.44%
|
1.72
+15.24%
|
1.49
-23.10%
|
1.94
|
| Payables |
|
0.12
+2.70%
|
0.12
-84.02%
|
0.73
+25.35%
|
0.58
|
| Accounts Payable |
|
0.01
-2.71%
|
0.01
-98.98%
|
0.62
+34.02%
|
0.46
|
| Other Payable |
|
0.11
+3.01%
|
0.11
-2.06%
|
0.11
-7.43%
|
0.12
|
| Stockholders Equity |
|
160.27
+4.54%
|
153.31
-3.72%
|
159.23
-7.48%
|
172.10
|
| Common Stock Equity |
|
160.27
+4.54%
|
153.31
-3.72%
|
159.23
-7.48%
|
172.10
|
| Capital Stock |
|
135.79
-2.55%
|
139.34
-7.53%
|
150.68
-3.86%
|
156.73
|
| Common Stock |
|
135.79
-2.55%
|
139.34
-7.53%
|
150.68
-3.86%
|
156.73
|
| Share Issued |
|
15.34
+0.00%
|
15.34
-3.32%
|
15.87
-3.13%
|
16.38
|
| Ordinary Shares Number |
|
15.34
+0.00%
|
15.34
-3.32%
|
15.87
-3.13%
|
16.38
|
| Retained Earnings |
|
24.48
+75.19%
|
13.97
+63.47%
|
8.55
-44.40%
|
15.37
|
| Total Equity Gross Minority Interest |
|
160.27
+4.54%
|
153.31
-3.72%
|
159.23
-7.48%
|
172.10
|
| Net Tangible Assets |
|
160.27
+4.54%
|
153.31
-3.72%
|
159.23
-7.48%
|
172.10
|
| Tangible Book Value |
|
160.27
+4.54%
|
153.31
-3.72%
|
159.23
-7.48%
|
172.10
|
| Available For Sale Securities |
|
0.74
+11.56%
|
0.67
-65.11%
|
1.91
-14.13%
|
2.22
|
| Cash Cash Equivalents And Federal Funds Sold |
|
1.32
-21.22%
|
1.68
+11.33%
|
1.51
+22.08%
|
1.23
|
| Derivative Product Liabilities |
|
1.50
+4.87%
|
1.43
+159.43%
|
0.55
-54.63%
|
1.21
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
158.27
+4.78%
|
151.06
-2.96%
|
155.66
-7.83%
|
168.88
|
| Investmentin Financial Assets |
|
159.41
+4.32%
|
152.81
-3.25%
|
157.94
-7.87%
|
171.43
|
No cash flow data available.
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|